Analysts estimate that Beam Therapeutics will report an earnings per share (EPS) of $-1.16.
The announcement from Beam Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings Track Record
In the previous earnings release, the company beat EPS by $0.03, leading to a 4.15% drop in the share price the following trading session.
Here's a look at Beam Therapeutics's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
-1.14
-1.42
-1.01
-1.34
EPS Actual
-1.11
-1.21
1.73
-1.22
Price Change %
-4.0%
-1.0%
-3.0%
-3.0%
Beam Therapeutics Share Price Analysis
Shares of Beam Therapeutics were trading at $22.93 as of November 01. Over the last 52-week period, shares are down 5.08%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
Analyst Observations about Beam Therapeutics
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Beam Therapeutics.
The consensus rating for Beam Therapeutics is Neutral, based on ...